Merge OrthoPACS software.
Published June 28, 2017 · Recall initiated: May 24, 2017
Summary
FDA records medical device Class II recall Z-2620-2017, published June 28, 2017 and initiated May 24, 2017. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 98 sites potentially have the affected versions; Lot: Versions 6.6, 6.6.1, and 6.6.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A migrated study that has annotations will display the annotations, but when a prior study is loaded that should have annotations, the second study will not display annotations.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Merge Healthcare, Inc.
- Distributor
- Distribution was made nationwide to medical facilities. There was no foreign/government/military distribution.
- Lot
- Versions 6.6, 6.6.1, and 6.6.2
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAMerge PACS and Merge OrthoPACS, medical imaging diagnostic workstationSeptember 2, 2026
- FDAMerge OrthoPACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAMerge PACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAVERICIS, Merge Cardio, Model/Catalog Number: Version 9.x, Software Version: 9.0.6 and 9.0.8; VERICIS is anMarch 26, 2025
- FDAMinivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by:July 5, 2017
- FDADePuy Mitek LATARJET EXPERIENCE Extraction Driver Product Code: 288216 Product Usage: The Latarjet CorticalJune 28, 2017
Questions about this recall
Was Merge OrthoPACS software. recalled?
Yes. FDA published recall Z-2620-2017 on June 28, 2017. Reported hazard: A migrated study that has annotations will display the annotations, but when a prior study is loaded that should have annotations, the second study will not display annotations.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit